← Eichor
Study identifier: NCT04805164 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Evaluation of the Efficiency of the Bone Substitute Cerament-G Locally Delivering Gentamicin in the Treatment of Chronic Osteomyelitis of Long Bones

Condition: Osteomyelitis Chronic  ·  Sponsor: Hospices Civils de Lyon

PhaseNA
Planned participants220
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

Chronic osteomyelitis is a serious osteoarticular infection that most often occurs in the long bones (tibia, femur, humerus), responsible for significant morbidity with risk of fracture and amputation. It is due to the presence of bacteria in the bone marrow, sometimes responsible for an intraosseous abscess. Chronic osteomyelitis can have a hematogenous or more often exogenous origin, after trauma or surgery. The bacteria involved have the ability to modify their metabolism and involve persistence mechanisms (such as biofilm) making them difficult to eradicate. The treatment of chronic osteomyelitis requires surgery, i.e. corticotomy, which means opening of the bone cortex to perform an endomedullary curettage to identify the bacteria, remove any sequestration (bone fragments to which the bacteria adhere as biofilm) and reduce the bacterial inoculum. At the same time, or at a second stage, a skin and soft tissue/muscle flap may be required, especially in patients with long-standing disease with embrittlement and adhesion of the skin and soft tissue to the underlying bone. Post-operatively, the patient receives a probabilistic systemic antibiotic therapy and then a systemic antibiotic therapy targeted on the identified germ, for a period of 3 months. The effectiveness of these antibiotics is based on their ability to penetrate bone tissue. Despite the progress made in both antibiotics and surgical treatments, the probability of failure (recurrence of infection) is around 20…

This description comes directly from the study's public registry record.

Talk to the study team

Tristan FERRY  ·  +33 4 72 07 24 81  ·  tristan.ferry@chu-lyon.fr

Always discuss trial participation with your own doctor first.

Locations (15)

CHU Amiens-PicardieAmiens, FranceRecruiting
CHU de BesançonBesançon, FranceNot Yet Recruiting
CHU BordeauxBordeaux, FranceRecruiting
APHPBoulogne-Billancourt, FranceNot Yet Recruiting
CHU BrestBrest, FranceRecruiting
CHU de CaenCaen, FranceRecruiting
CHU de LilleLille, FranceNot Yet Recruiting
Hospices Civils de LyonLyon, FranceRecruiting
Hospices Civils de LyonLyon, FranceNot Yet Recruiting
CHRU NancyNancy, FranceNot Yet Recruiting
CHU de NantesNantes, FranceRecruiting
CHU de NîmesNîmes, FranceNot Yet Recruiting

+ 3 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04805164